| Selectins promote tumor metastasis H Läubli, L Borsig Seminars in cancer biology 20 (3), 169-177, 2010 | 533 | 2010 |
| A red meat-derived glycan promotes inflammation and cancer progression AN Samraj, OMT Pearce, H Läubli, AN Crittenden, AK Bergfeld, K Banda, ... Proceedings of the National Academy of Sciences 112 (2), 542-547, 2015 | 439 | 2015 |
| Sialic acids in cancer biology and immunity OMT Pearce, H Läubli Glycobiology 26 (2), 111-128, 2016 | 412 | 2016 |
| Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma H Läubli, C Balmelli, M Bossard, O Pfister, K Glatz, A Zippelius Journal for immunotherapy of cancer 3 (1), 11, 2015 | 338 | 2015 |
| The immune system and cancer evasion strategies: therapeutic concepts S Muenst, H Läubli, SD Soysal, A Zippelius, A Tzankov, S Hoeller Journal of internal medicine 279 (6), 541-562, 2016 | 337 | 2016 |
| Association of checkpoint inhibitor–induced toxic effects with shared cancer and tissue antigens in non–small cell lung cancer F Berner, D Bomze, S Diem, OH Ali, M Fässler, S Ring, R Niederer, ... JAMA oncology 5 (7), 1043-1047, 2019 | 306 | 2019 |
| B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma J Griss, W Bauer, C Wagner, M Simon, M Chen, ... Nature communications 10 (1), 4186, 2019 | 274 | 2019 |
| Involvement of a non-human sialic acid in human cancer AN Samraj, H Läubli, N Varki, A Varki Frontiers in oncology 4, 33, 2014 | 230 | 2014 |
| Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells MA Stanczak, SS Siddiqui, MP Trefny, DS Thommen, KF Boligan, ... The Journal of clinical investigation 128 (11), 4912-4923, 2018 | 227 | 2018 |
| Targeted glycan degradation potentiates the anticancer immune response in vivo MA Gray, MA Stanczak, NR Mantuano, H Xiao, JFA Pijnenborg, ... Nature chemical biology 16 (12), 1376-1384, 2020 | 219 | 2020 |
| Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer H Läubli, OMT Pearce, F Schwarz, SS Siddiqui, L Deng, MA Stanczak, ... Proceedings of the National Academy of Sciences 111 (39), 14211-14216, 2014 | 216 | 2014 |
| L-Selectin Facilitation of Metastasis Involves Temporal Induction of Fut7-Dependent Ligands at Sites of Tumor Cell Arrest H Läubli, JL Stevenson, A Varki, NM Varki, L Borsig Cancer research 66 (3), 1536-1542, 2006 | 215 | 2006 |
| Altered cell adhesion and glycosylation promote cancer immune suppression and metastasis H Läubli, L Borsig Frontiers in immunology 10, 484841, 2019 | 182 | 2019 |
| Selectin-mediated activation of endothelial cells induces expression of CCL5 and promotes metastasis through recruitment of monocytes H Läubli, KS Spanaus, L Borsig Blood, The Journal of the American Society of Hematology 114 (20), 4583-4591, 2009 | 157 | 2009 |
| Targeting sialic acid–Siglec interactions to reverse immune suppression in cancer OJ Adams, MA Stanczak, S von Gunten, H Läubli Glycobiology 28 (9), 640-647, 2018 | 143 | 2018 |
| Sialic acid–binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses H Läubli, A Varki Cellular and Molecular Life Sciences 77 (4), 593-605, 2020 | 137 | 2020 |
| Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events H Läubli, C Balmelli, L Kaufmann, M Stanczak, M Syedbasha, D Vogt, ... Journal for immunotherapy of cancer 6, 1-10, 2018 | 136 | 2018 |
| Selectins as mediators of lung metastasis H Läubli, L Borsig Cancer Microenvironment 3, 97-105, 2010 | 112 | 2010 |
| Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non‐small cell lung cancer I Alborelli, K Leonards, SI Rothschild, LP Leuenberger, S Savic Prince, ... The Journal of pathology 250 (1), 19-29, 2020 | 107 | 2020 |
| Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs H Läubli, F Alisson-Silva, MA Stanczak, SS Siddiqui, L Deng, A Verhagen, ... Journal of Biological Chemistry 289 (48), 33481-33491, 2014 | 107 | 2014 |
Alfred ZippeliusProfessor of Translational Oncology, Co-Head Medical OncologyBestätigte E-Mail-Adresse bei usb.ch
